Novacyt S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALNOV.PA research report →
About the company
Founded in 2006 and headquartered in Vélizy-Villacoublay, France, Novacyt S. A. and its subsidiaries are actively involved in the full lifecycle of diagnostic products, encompassing development, manufacturing, custom design, and global commercialization.
- CEO
- Lyn Dafydd Rees
- IPO
- 2012
- Employees
- 234
- HQ
- Le Vésinet, FR
Price Chart
- Market Cap
- $30.32M
- P/E
- -0.53
- P/S
- 0.89
- P/B
- 1.09
- EV/EBITDA
- -1.41
- Div Yield
- 0.00%
- Gross Margin
- 39.82%
- Op Margin
- -71.51%
- Net Margin
- -159.60%
- ROE
- -121.33%
- ROIC
- -54.00%
- Revenue
- $20.40M · 3.94%
- Net Income
- $-23,311,024 · 44.18%
- EPS
- $-0.33 · 44.07%
- Op Income
- $-13,175,929
- FCF YoY
- 17.97%
- 52W High
- $1.04
- 52W Low
- $0.29
- 50D MA
- $0.47
- 200D MA
- $0.44
- Beta
- 1.10
- Avg Volume
- 1.23M
Get TickerSpark's AI analysis on ALNOV.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALNOV.PA coverage
Recent articles, reports, and earnings notes.
No research on ALNOV.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALNOV.PA report →Similar companies
Peers in the same neighborhood.